SG11201405743QA - Liposomal delivery system - Google Patents

Liposomal delivery system

Info

Publication number
SG11201405743QA
SG11201405743QA SG11201405743QA SG11201405743QA SG11201405743QA SG 11201405743Q A SG11201405743Q A SG 11201405743QA SG 11201405743Q A SG11201405743Q A SG 11201405743QA SG 11201405743Q A SG11201405743Q A SG 11201405743QA SG 11201405743Q A SG11201405743Q A SG 11201405743QA
Authority
SG
Singapore
Prior art keywords
delivery system
liposomal delivery
liposomal
delivery
Prior art date
Application number
SG11201405743QA
Inventor
Victoria Kett
Helmy Yusuf
Helen Mccarthy
Kun Hung Chen
Original Assignee
Univ Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Belfast filed Critical Univ Belfast
Publication of SG11201405743QA publication Critical patent/SG11201405743QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201405743QA 2012-03-16 2013-03-15 Liposomal delivery system SG11201405743QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1204632.2A GB201204632D0 (en) 2012-03-16 2012-03-16 Delivery system
PCT/EP2013/055471 WO2013135892A1 (en) 2012-03-16 2013-03-15 Liposomal delivery system

Publications (1)

Publication Number Publication Date
SG11201405743QA true SG11201405743QA (en) 2014-10-30

Family

ID=46052024

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405743QA SG11201405743QA (en) 2012-03-16 2013-03-15 Liposomal delivery system

Country Status (6)

Country Link
US (1) US20150079156A1 (en)
EP (1) EP2825153A1 (en)
CA (1) CA2867417A1 (en)
GB (1) GB201204632D0 (en)
SG (1) SG11201405743QA (en)
WO (1) WO2013135892A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722465B1 (en) * 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
WO2023057871A1 (en) * 2021-10-04 2023-04-13 Novartis Ag Surfactant stabilizers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
DK1059092T3 (en) * 1999-06-08 2006-03-27 Gentium Spa Use of complexes of cationic liposomes and polydeoxyribonucleotides as drugs
CN100488491C (en) * 2002-11-21 2009-05-20 派维翁生物技术有限公司 High-efficiency fused vesicles, methods of producing them, and pharmaceutical compositions containing same
EP1512393A1 (en) * 2003-09-08 2005-03-09 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Process for the production of homogeneous liposomes and lipoplexes
TWI262798B (en) * 2003-12-31 2006-10-01 Ind Tech Res Inst Liposome and drug deliver system
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
EP1833838A2 (en) * 2004-12-14 2007-09-19 Applera Corporation, Applied Biosystems Group Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides

Also Published As

Publication number Publication date
CA2867417A1 (en) 2013-09-19
WO2013135892A1 (en) 2013-09-19
EP2825153A1 (en) 2015-01-21
GB201204632D0 (en) 2012-05-02
US20150079156A1 (en) 2015-03-19

Similar Documents

Publication Publication Date Title
ZA201502352B (en) Liposomal drug delivery system
GB201215193D0 (en) Order delivery system
EP2683328A4 (en) Delivery system
GB201121069D0 (en) Delivery system
HK1215677A1 (en) Transdermal delivery system
ZA201406171B (en) Dispensing system
ZA201406174B (en) Dispensing system
EP2830693A4 (en) Anesthetic delivery system
GB201217418D0 (en) System
GB201213491D0 (en) Content delivery system
EP2903491A4 (en) Dispensing system
HK1214202A1 (en) Dispensing system
SG10201609440WA (en) Multi-additive delivery system
EP2926712A4 (en) Gas delivery system
RS56716B1 (en) Suction roll system
GB201506647D0 (en) Water delivery system
SG11201405743QA (en) Liposomal delivery system
GB201214708D0 (en) Secure delivery system
GB201200661D0 (en) Delivery vesicles
GB201108399D0 (en) Secure delivery system
GB201209642D0 (en) Dispensing system
GB201220308D0 (en) Passerelle system
GB201220256D0 (en) Ourtizanz system
GB201219191D0 (en) Mc-mat system
GB201212060D0 (en) Tranportation system